BRIEF: Bendamustine and Rituximab In Elderly Follicular: A Multicentric Phase II Study Evaluating the Benefit of a Short Induction Treatment by Bendamustine and Rituximab Followed by Maintenance Therapy With Rituximab In Elderly (greater than or equal to 60 Years Old) Patients With Untreated Follicular Lymphoma, Patients with an Intermediate or High FLIPI Score.

Trial Profile

BRIEF: Bendamustine and Rituximab In Elderly Follicular: A Multicentric Phase II Study Evaluating the Benefit of a Short Induction Treatment by Bendamustine and Rituximab Followed by Maintenance Therapy With Rituximab In Elderly (greater than or equal to 60 Years Old) Patients With Untreated Follicular Lymphoma, Patients with an Intermediate or High FLIPI Score.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2017

At a glance

  • Drugs Bendamustine (Primary) ; Rituximab (Primary)
  • Indications Follicular lymphoma
  • Focus Therapeutic Use
  • Acronyms BRIEF
  • Most Recent Events

    • 07 Sep 2017 Planned End Date changed from 1 jun 2015 to 1 Dec 2017.
    • 05 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 18 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top